• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-

Section Contents Menu

  • Enforcement Actions
  • -
     

    2002 Warning Letters

    -

    Recently Posted | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |

    Tobacco Retailer Warning Letters

     

    -

    Warning Letters for 2002

    Recently Posted | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

     

    * Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

    * N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

    Read more about warning and close-out letters

     

    Posted on May 04, 2009

    Letter Issue Date Company Name Issuing Office Subject Close Out Date
    October 15, 2002 Ports Seafood, Inc. San Francisco District Office Seafood HACCP/Adulterated N/A *
    October 15, 2002 The Outer Banks Hospital Atlanta District Office Mammography Quality Standards N/A *
    October 11, 2002 Ranbaxy Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Kaiser FDN Health Plan Colorado Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Mikart Inc Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 National Pharmpak Services Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Dartmouth Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Nucare Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Sovereign Pharmaceutical Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Amerisource Health Services Corp. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Compound Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Alphagen Laboratories Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Respa Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Ambi Pharmaceuticals Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Links Pharmaceutical Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Keil Laboratories Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Sage Pharmaceutical Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Wal Mart Stores Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 RX PAK DIV Mckesson HBOC Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 H J Harkins Co Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Amide Pharmaceutical Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Drug Distributors Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Vintage Pharmaceutical Inc Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Direct Dispensing Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Anabolic Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Mutual Pharmaceutical Co Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Major Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Caraco Pharmaceutical Laboratories Ltd. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Cheshire Pharmaceutical Systems Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Southwood Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Prestige Packaging Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Boca Pharmacal Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Celltech Manufacturing Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Eckerd Drug Co Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Capellon Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Iopharm Laboratories Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Cypress Pharmaceutical Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Pharmaceutical Utilization Management Program VA Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Duramed Pharmceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Goldline Laboratories Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Thrift Drug Services Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Murfreesboro Pharmaceutical Nursing Supply Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 M G Acquistion LLC Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Keil Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Biovail Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 PFAB LP - Pharmafab Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Allscripts Healthcare Solutions Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 UBC Pharma Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 Jerome Stevens Pharmaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
    October 11, 2002 MCR American Phamaceuticals Inc. Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *


    -
     

    Contact FDA

    ICECI Warning Letters

    Division of Freedom of Information (HFI-35)

    Food and Drug Administration

    5600 Fishers Lane

    Rockville, MD 20857
    -
    -
    -
    -